Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Post by
MetzGER
on Oct 18, 2023 3:58am
SHISEIDO WILL COMMERCIALIZE RCH-01
THEY WILL commercialize RepliCels Technology in Japan. And RepliCel still has all rights of the other continents Europe, USA, Australia... Shiseido is very convinced about RepliCels hair Regeneration
...more
(1)
•••
toniZ1
X
View Profile
View Bullboard History
Comment by
toniZ1
on Oct 18, 2023 3:03am
RE:RE:RE:Could have been worse
lol sure it was his fault. Come on, only Replicel is responsible for this outcome and only you for investing in them. Replicel did not fulfill terms of the agreement so Shiseido terminated it years
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Oct 18, 2023 1:25am
RE:RE:RE:Could have been worse
Nope. The stock had already tummbled.. I sold after that drop.
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Oct 18, 2023 12:45am
RE:RE:Could have been worse
Thanks Genie so you fuc..ked the Share Price. Nice Job
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Oct 17, 2023 7:29pm
RE:Could have been worse
I think the clouds just got a lot darker. we've all been saying this company is super dependent on Shiseido... I don't see that changing. They needed the win to raise cash from other
...more
(56)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Oct 17, 2023 6:06pm
Could have been worse
I was fearing the worst today. It was bad that we are now trading at $.065 but the volume was low (209,000 shares) which is .003% of the outstanding shares. O.K. let's stop the crying.
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Oct 17, 2023 12:13pm
RE:What Now ?
Don't know if I'm missing something here but I thought they were going to the arbitration for breach of contract. If shiseido terminated the agreement in 2013 then any studies they'
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Post by
Genie29j
on Oct 17, 2023 10:55am
The selling has begun…
Sad sad day. An update would be good about now to stop the bleeding.
(56)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Oct 17, 2023 10:24am
What Now ?
This is not time to panic and sell your shares for nothing. Firstly by today's trading activity the market baked in a Replicel loss of the Arbitration and has peged it's current value at $.10.
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Oct 17, 2023 9:02am
RE:RE:RE:RE:RE:RE:It is Not the end - it is the beginning!!
Why should somebody sign an agreement before they had the Proof that Shiseido is convinced of the product and before the product is Final Tested? If Shiseido commercialize the product in ASEAN then
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Oct 17, 2023 9:01am
RE:RE:RE:RE:RE:It is Not the end - it is the beginning!!
I mean nothing has changed from a revenue point of view
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Oct 17, 2023 8:19am
RE:RE:RE:RE:RE:It is Not the end - it is the beginning!!
Because no one else has signed an agreement for RCH-01 any where in the world
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Oct 17, 2023 7:23am
RE:RE:RE:RE:It is Not the end - it is the beginning!!
RepliCel has the rights to commercialize RCH-01 in Europe, US, Australia and other countries out of ASEAN. Why you don't See this Big worth? it isnt only about the Dermal injector
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Oct 17, 2023 7:21am
RE:RE:RE:It is Not the end - it is the beginning!!
The only glimmer of hope MainPointe has also agreed to pay the costs related to securing FDA approvals to market launch RepliCel's dermal injector and consumables (the “RepliCel Injector
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle
Learn About a Mining Portfolio of More Than 250 Projects and Royalties Across North America
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
New electric industrial heat technology to reduce greenhouse gas emissions
Discover Options Trading Strategies to Minimize your Tax Burden